BIOCHEMICAL CHANGES IN BLOOD AND BODY FLUIDS ASSOCIATED WITH TUBERCULOSIS
Abstract
Tuberculosis (TB) remains a major global health challenge, with complex biochemical alterations occurring in affected patients. This study investigates the biochemical changes in blood and body fluids associated with tuberculosis to identify potential biomarkers for diagnosis and monitoring. We conducted a comprehensive analysis of blood samples and various body fluids from a cohort of TB patients, examining key biochemical parameters including electrolytes, proteins, lipids, and metabolic byproducts. Our findings reveal significant deviations from normal ranges in several markers, suggesting a profound impact of TB on systemic biochemistry. Notably, alterations in serum proteins and lipid profiles were observed, which could be linked to the disease's inflammatory response and metabolic disturbances. The study highlights the potential of these biochemical markers for improving diagnostic accuracy and tracking disease progression. These insights contribute to a better understanding of TB’s impact on biochemical pathways and may aid in the development of novel diagnostic and therapeutic approaches.
Keywords
Biochemical changes, tuberculosis, blood analysisHow to Cite
References
Agarwal MK, Nath J, Mukerji PK, Srivastava VML. A study of serum Adenosine deaminase activity in sputum negative patients of pulmonary tuberculosis. Ind J Tub 1991; 38:139-141.
Maher D, Chaulet P, Spinaci S, Harries A (1997). Treatment of tuberculosis: Guidelines for National Programmes, 2nd Ed. Geneva: World Health Organization.
Centres for Disease Control and Prevention (CDC). "Emergence of Mycobacterium tuberculosis with extensive resistance to second-line drugs-worldwide, 2000-2004" MMWR Morb Mortal Wkly Rep2006;55(1 1):301-5.
Dimakou K, Hillas G, Bakakos P Adenosinedeaminase activity and its isoenzymes in the sputum of patients with pulmonary tuberculosis. Int J Tuberc Lung Dis2009;13(6):744-748.
Shah N, Asian N (1992). Adenosine deaminase activity levels and its diagnostic value. Pak Med J1992;251 :217-221.
FerraraG, Losi M, Meacci M, Meccugni B, Piro R, Roversi P, Bergamini BM, D'Amico R, Marchegiano P, Rumpianesi F. Routine hospital use of a new commercial whole blood interferon-gamma assay for the diagnosis of tuberculosis infection. Am J Respir Grit Care Med2005; 172:631-635.
Tillet W, Francis TW. Origin of CRP and its uses. Chest 1930; 30:151-96.
Harada N (2006). Characteristics of a diagnostic method for tuberculosis infection based on whole blood interferon-gamma assay. Kekkaku 2006;81(11):681-6.
Dacie JV, Lewis SM. Haematological tests. Practical haematology; Edinburgh: Churchill Living stone; 20061:54-78
Giusti G, Galanti B. Adenosine deaminase. In: Hergmyer HU (RD). Method of enzymatic analysis. New York: Verlag Chemic Weinhein and Academic Press1974:1092-1099.
Kidmark CO. C-reactive protein. Scand J Clin Lab Invest, 1972;29:407.
License
Copyright (c) 2024 Dr. Shabbir Syed
This work is licensed under a Creative Commons Attribution 4.0 International License.